Merck
MRK
#48
Rank
โ‚น30.674 T
Marketcap
โ‚น12,420
Share price
0.32%
Change (1 day)
82.29%
Change (1 year)

EPS for Merck (MRK)

EPS in 2026 (TTM): โ‚น305.21

According to Merck's latest financial reports the company's current EPS (TTM) is โ‚น341.01. In 2025 the company made an earnings per share (EPS) of โ‚น697.33 an increase over its 2024 EPS that were of โ‚น644.76.

EPS history for Merck from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น305.21-56.23%
2025โ‚น697.338.15%
2024โ‚น644.764308.46%
2023โ‚น14.63-97.32%
2022โ‚น546.5810.92%
2021โ‚น492.7784.68%
2020โ‚น266.83-27.2%
2019โ‚น366.5163.44%
2018โ‚น224.24151.11%
2017โ‚น89.30-54.58%
2016โ‚น196.5930.21%
2015โ‚น150.98-61.99%
2014โ‚น397.17180.51%
2013โ‚น141.59-31.82%
2012โ‚น207.676.62%
2011โ‚น194.77

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น833.20 144.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น669.64 96.37%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น124.96-63.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น344.22 0.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,692 689.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,381 305.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น244.17-28.40%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
โ‚น339.59-0.42%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น370.72 8.71%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚น130.68-61.68%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel